Dahl Andrew M. 4

What Happened
Andrew M. Dahl, Senior Vice President and Corporate Controller at Edwards Lifesciences (EW), sold 567.527 shares in an open-market sale on May 29, 2026. The shares were disposed at $86.08 each, for proceeds of approximately $48,853. This was a sale (not a purchase); sales by insiders can be routine and do not necessarily signal a change in company outlook.

Key Details

• Transaction date: 2026-05-29
• Transaction type: Open-market sale (Code S)
• Shares sold: 567.527
• Price per share: $86.08
• Proceeds: $48,853 (approx.)
• Shares owned after transaction: Not specified in the provided excerpt of the Form 4
• Filing timeliness: Reported on 2026-05-29 (same-day filing in this record)
• Remarks on the filing: "This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person." No 10b5-1 plan, tax withholding, or other footnotes were indicated in the provided details.

Context
This was a straightforward open-market sale. For retail investors, purchases by insiders are often considered more informative about insider sentiment; sales can be routine (diversification, tax planning, etc.). The filing contains no additional notes suggesting a cashless exercise, gift, or 10% ownership change.